Vapourtec’s R-Series flow chemistry system, equipped with a UV-150 photochemical reactor, has been cited in research by scientists* at Novo Nordisk in the C-terminal α-amination of peptides and ...

Roche has reported early-stage clinical data with an oral GLP-1 agonist ... from a phase 1 trial of a once-daily pill called CT-966, which revealed an average weight loss of 7.3% at four weeks ...

Scientists at Novo Nordisk have demonstrated a photochemically enabled strategy for the functionalisation of peptides and ...

The rise in GLP-1 drugs is undeniable. Morgan Stanley projects that by 2035, 24 million Americans, or 7% of the population, will be using these medications. But that estimate may ...

A study conducted using electronic health record data from a collective of U.S. health care systems found that most adults ...

SLW: The part of dairy that is very well-positioned to assist consumers on their GLP-1 journey is yogurt. The functional ...

As GLP-1 medications such as Ozempic, Mounjaro and Wegovy rise in popularity, so do concerns over their side effects.

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a few years ago that its use became mainstream. Originally crafted to help ...

The company said that, based on a pharmacokinetic study, it has plumped for a once-daily, modified-release formulation of GLP-1 agonist danuglipron ... % weight loss after 36 weeks in a mid ...

7/36-40 Underhill Avenue, Indooroopilly is a 4 bedroom apartment. What are the key property features of 7/36-40 Underhill Avenue, Indooroopilly? Explore all key property features for 7/36-40 ...

Kendrick Lamar has taken the lead for his first UK Number 1 single. Not Like Us charges up ... and All The Stars (7) could be present in the Top 10 come Friday. Didn’t you hear she’s a Busy ...